NEW YORK, Nov. 18, 2016 -- Safirstein Metcalf LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of purchasers of Supreme Industries, Inc. (“Supreme” or the “Company”) (NYSE:STS) securities from July 22, 2016 and October 21, 2016, inclusive (the "Class Period").
If you purchased Supreme securities during the Class Period, you may, no later than January 3, 2017, request that the Court appoint you lead plaintiff of the proposed class. A lead plaintiff is a representative party that acts on behalf of all class members in directing the litigation. Any member of the purported class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.
If you would like more information about getting involved in the Supreme Securities Class Action, please contact Sheila Feerick at 1-800-221-0015, or email [email protected].
According to the complaint, on July 22, 2016, Supreme officials discussed the company's earnings for the second quarter of 2016 in a conference call. Matthew W. Long, the company's Chief Financial Officer stated, "the backlog is going to settle more towards the way it looked Q3 last year." The complaint alleges, however, that the statement was misleading because it failed to disclose that the backlog figure from the third quarter of 2015 was a result of the timing of several large orders placed in that quarter, and the backlog figure for the third quarter of 2016 would not be close to the backlog figure of the third quarter of 2015.
On October 21, 2016, Supreme issued a press release announcing that at the end of Q3 2016, order backlog was $58.1 million, down from the $74.4 million in order backlog at the end of Q3 2015. On the same day, the company held a conference call during which it discussed the decline in backlog, stating, "The lower backlog comparison is due to two large fleet replacement orders and the timing of an annual fleet account order received during the third quarter of last year." Later that day, Cliffside Research published a report noting heavy selling activity in 2016 by Supreme insiders with knowledge of the company's struggling business. On this news, Supreme stock fell $2.38 per share, or over 17%, to close at $11.30 per share on October 24, 2016.
About Safirstein Metcalf LLP
Safirstein Metcalf LLP focuses it practice on shareholder rights. The law firm also practices in the areas of antitrust and consumer protection. All of the Firm’s legal endeavors are rooted in its core mission: provide investor and consumer protection.
Attorney advertising. Prior results do not guarantee a similar outcome.
Safirstein Metcalf LLP Peter Safirstein, Esq. 1250 Broadway 27th Floor New York, NY 10001 1-800-221-0015 [email protected]


Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Winter Storm Devin Triggers Massive Flight Cancellations and Travel Disruptions Across the U.S.
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Brazilian Oil Workers’ Strike Continues as Key Petrobras Union Rejects Proposal
California DMV Proposes New Safety Rules for Autonomous Vehicles After Waymo Incidents
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio 



